Drug Type Small molecule drug |
Synonyms CRB 317, CRB-317 |
Target |
Mechanism CB2 agonists(Cannabinoid CB2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | US | - | |
Inflammation | Preclinical | US | - |